We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ranbaxy Reports Positive Malaria Study Results; Plans NDA by 2009
Ranbaxy Reports Positive Malaria Study Results; Plans NDA by 2009
December 13, 2005
Ranbaxy Laboratories announced positive clinical study results for its experimental malaria drug, RBx 11160, which it is touting as an affordable alternative to current therapies.